Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-27

Clinical Trial Update: Budesonide/Formoterol Turbuhaler® Versus Terbutaline Nebulization as Reliever Therapy in Children With Moderate Asthma Exacerbation [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing budesonide/formoterol Turbuhaler against terbutaline nebulization as reliever therapy in children with moderate asthma exacerbation wa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Terbutaline (terbutaline)
  • budesonide/formoterol Turbuhaler (budesonide/formoterol)

Snippet

Sponsor: Centre Hospitalier Intercommunal Creteil | Conditions: Asthma in Children | Phase 3 | Status: TERMINATED